{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:30:49Z","timestamp":1767598249299,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ahj.2010.10.012","type":"journal-article","created":{"date-parts":[[2010,12,16]],"date-time":"2010-12-16T04:33:44Z","timestamp":1292474024000},"page":"S22-S27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"S","title":["Evaluation and management of special subgroups after primary percutaneous coronary intervention"],"prefix":"10.1016","volume":"160","author":[{"given":"Leonardo","family":"De Luca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Tomai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Verdoia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2010.10.012_bb0005","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0735-1097(98)00579-8","article-title":"Effect of age on outcome with primary angioplasty versus thrombolysis","volume":"33","author":"Holmes","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.10.012_bb0010","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/eurheartj\/ehi110","article-title":"Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty","volume":"26","author":"De Luca","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2010.10.012_bb0015","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijcard.2006.07.143","article-title":"Comparison between stenting and balloon in elderly patients undergoing primary angioplasty for ST-segment elevation myocardial infarction","volume":"119","author":"De Luca","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2010.10.012_bb0020","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1001\/jama.294.24.3108","article-title":"Excess dosing of antiplatelet and antithrombin agents in the treatment of non\u2013ST-segment elevation acute coronary syndromes","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2010.10.012_bb0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2165\/00002512-200016030-00003","article-title":"Platelet glycoprotein IIb\/IIIa receptor antagonists and their use in elderly patients","volume":"16","author":"Mak","year":"2000","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ahj.2010.10.012_bb0030","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2010.10.012_bb0035","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2010.10.012_bb0040","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0002-9149(97)00676-0","article-title":"In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation","volume":"80","author":"Pan","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2010.10.012_bb0045","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/diacare.29.04.06.dc05-1891","article-title":"Impact of routine stenting on clinical outcome in diabetic patients undergoing primary angioplasty for ST-segment elevation myocardial infarction","volume":"29","author":"De Luca","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2010.10.012_bb0050","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ahj.2005.02.015","article-title":"Effects of abciximab and preprocedural glycemic control in diabetic patients undergoing elective coronary stenting","volume":"149","author":"De Luca","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2010.10.012_bb0055","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.jacc.2006.01.040","article-title":"Glucose-insulin-potassium infusion in patients with acute myocardial infarction without signs of heart failure: the Glucose-Insulin-Potassium Study (GIPS)-II","volume":"47","author":"Timmer","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.10.012_bb0060","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.amjcard.2005.01.088","article-title":"Zwolle Myocardial Infarction Study Group. Comparison of myocardial perfusion after successful primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction with versus without diabetes mellitus","volume":"95","author":"Timmer","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2010.10.012_bb0065","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11239-008-0296-9","article-title":"Benefits of pharmacological facilitation with glycoprotein IIb-IIIa inhibitors in diabetic patients undergoing primary angioplasty for STEMI. A subanalysis of the EGYPT cooperation","volume":"28","author":"De Luca","year":"2009","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ahj.2010.10.012_bb0070","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(10)61088-4","volume":"376","author":"Mehta","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2010.10.012_bb0075","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.108.791061","volume":"118","author":"Wiviott","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.10.012_bb0080","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2004.10.054","article-title":"Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction","volume":"45","author":"Prasad","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.10.012_bb0085","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0300-8932(09)70892-9","article-title":"Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials","volume":"62","author":"Iijima","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.ahj.2010.10.012_bb0090","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11239-009-0420-5","article-title":"Impact of diabetes on long-term outcome in STEMI patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors and BMS or DES","volume":"30","author":"De Luca","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ahj.2010.10.012_bb0095","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2459\/JCM.0b013e3283347e24","article-title":"Rationale and design of the Randomized comparison of XiEnce V and Multilink VisioN coronary stents in the sAme muLtivessel patient with chronic kidney disease (RENAL-DES) study","volume":"11","author":"Tomai","year":"2010","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.ahj.2010.10.012_bb0100","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/01.CIR.0000103623.63687.21","article-title":"Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction","volume":"108","author":"Sadeghi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.10.012_bb0105","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ahj.2007.02.018","article-title":"Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty","volume":"153","author":"Marenzi","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2010.10.012_bb0110","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1253\/circj.71.1354","article-title":"Serum creatinine on admission predicts long-term mortality in acute myocardial infarction patients undergoing successful primary angioplasty: data from the Heart Institute of Japan Acute Myocardial Infarction (HIJAMI) Registry","volume":"71","author":"Yamaguchi","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2010.10.012_bb0115","first-page":"493","article-title":"Elevated admission serum creatinine predicts poor myocardial blood flow and more one-year mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention","volume":"21","author":"Zhao","year":"2009","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.ahj.2010.10.012_bb0120","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jacc.2007.11.045","article-title":"Cockcroft-Gault versus Modification of Diet in Renal Disease. Importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non\u2013ST-segment elevation acute coronary syndromes","volume":"51","author":"Melloni","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.10.012_bb0125","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"Mehran","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.10.012_bb0130","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.10.012_bb0135","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.amjcard.2009.06.049","article-title":"A comparison of clopidogrel responsiveness in patients with versus without chronic renal failure","volume":"104","author":"Park","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2010.10.012_bb0140","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2710.2009.01068.x","article-title":"Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease","volume":"34","author":"Small","year":"2009","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.ahj.2010.10.012_bb0145","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/CIRCULATIONAHA.106.613596","article-title":"Cardiogenic shock. Current concepts and improving outcomes","volume":"117","author":"Reynolds","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.10.012_bb0150","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.0000134791.68010.FA","volume":"110","author":"Antman","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.10.012_bb0155","doi-asserted-by":"crossref","first-page":"890.e9","DOI":"10.1016\/j.ahj.2005.08.020","article-title":"Restrictive physiology in cardiogenic shock: observations from echocardiography","volume":"151","author":"Reynolds","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2010.10.012_bb0160","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/eurheartj\/ehp292","article-title":"Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials","volume":"17","author":"Cheng","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2010.10.012_bb0165","first-page":"521","article-title":"Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock","volume":"13","author":"Windecker","year":"2007","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.ahj.2010.10.012_bb0170","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0300-9572(02)00266-6","article-title":"Predictors of survival in unselected patients with acute myocardial infarction requiring continuous catecholamine support","volume":"55","author":"Schreiber","year":"2002","journal-title":"Resuscitation"},{"key":"10.1016\/j.ahj.2010.10.012_bb0175","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijcard.2006.01.024","article-title":"Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock","volume":"114","author":"Valente","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2010.10.012_bb0180","first-page":"CD003709","article-title":"Vasopressors for shock","author":"M\u00fcllner","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ahj.2010.10.012_bb0185","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/eurheartj\/ehi875","article-title":"Evidence-based use of levosimendan in different clinical settings","volume":"16","author":"De Luca","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2010.10.012_bb0190","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/CCM.0b013e3181809846","article-title":"Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction","volume":"36","author":"Fuhrmann","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ahj.2010.10.012_bb0195","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/eurheartj\/ehm075","article-title":"Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study","volume":"28","author":"Dzav\u00edk","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2010.10.012_bb0200","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.297.15.joc70035","article-title":"Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock. The TRIUMPH randomized controlled trial","volume":"297","author":"The TRIUMPH Investigators","year":"2007","journal-title":"JAMA"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870310009129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870310009129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:42:47Z","timestamp":1757569367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870310009129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0002870310009129"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2010.10.012","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation and management of special subgroups after primary percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2010.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}